JENNA BREWER: Open Payments
NPI 1679167738 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 8 payments from 8 companies in 2025. Trend: 2023 $430 · 2024 $230 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 1 | $34 |
| Grifols USA, LLC | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| GENZYME CORPORATION | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: DUPIXENT, Tyvaso, Prolastin-C Liquid, GLASSIA, WINREVAIR, Zemaira, YUPELRI.
Industry payments across TN — which companies pay providers there.
